Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about the schedule of an analyst/investor meeting to be held on October 21st and 22nd, 2026. The meeting will be held with ICICI Securities, Kotak Securities, and Nuvama Wealth. The meeting details are as follows: ICICI Securities - In-person meeting on October 21st at 4:00 PM, Kotak Securities - Virtual group meeting on October 22nd from 3:00 PM to 4:00 PM, and Nuvama Wealth - Virtual meeting on October 22nd at 4:30 PM.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about GST inspection and search proceedings initiated by Maharashtra State GST officials at its Registered Office. The company has cooperated with the officials and provided necessary information and documents. The company has taken steps to address the observations raised by the GST authorities and has paid the tax and interest liability communicated in connection with the proceedings.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that the entire holding of the company's shares are in demat form and no requests for rematerialisation were received during the quarter ended September 30, 2026.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about the schedule of an analyst/investor meeting to be held on October 2, 2026, with two sessions at 3:00 PM and 4:30 PM IST.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about the revised schedule of its Analyst/Investor Meeting, which will now be held in-person with individual meetings instead of a group virtual meet.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about a scheduled analyst/investor meeting on October 1, 2026, with no unpublished price sensitive information to be discussed.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 21, 2026, and informed the Exchange regarding voting results. All three resolutions proposed in the Notice of the 24th AGM have been duly approved by the requisite majority of the shareholders.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited held its 24th Annual General Meeting (AGM) on September 21, 2026, through video conferencing. The meeting was attended by 34 members, and resolutions were passed for the adoption of financial statements, appointment of directors, and other special business.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has commenced commercial production/operations at its Semiconductor & Specialty Gas debulking and blending facility at Khalapur, Maharashtra. The facility is expected to be a key contributor to the company's production capacities and revenue growth.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about the schedule of an Analyst/Investor Meeting on September 8, 2026, at the company's registered office. The meeting will be held virtually with Canara HSBC Life Insurance. No unpublished price sensitive information (UPSI) will be discussed.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about the completion of dispatch of the AGM notice and e-voting information for the 24th Annual General Meeting through newspaper advertisements, as per Section 108 of the Companies Act, 2013, and Regulations 44 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about the transcript of the Investor Conference held on Monday, 17th August, 2026, at 04.00 P.M. IST with regard to the business and financial performance of the Company for the quarter ended 30th June, 2026. The transcript has also been uploaded on the Company’s website.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its Rights Issue. The report indicates no deviation from the objects of the issue, and the Monitoring Agency has declared that the report provides an objective view of the utilization of the issue proceeds.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has made available the audio recording of its earnings conference call held on August 17, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has informed the Exchange about Investor Presentation for the Quarter ended 30th June, 2026, to be made to the investors and analysts.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has announced its unaudited financial results for Q1 FY26-27, reporting a 12.78% YoY increase in total revenue to ₹124.68 crore, a 75.85% YoY increase in EBITDA to ₹25.27 crore, and a 79.15% YoY increase in PAT to ₹18.57 crore.

Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of proceeds from its Initial Public Offer (IPO). The report states that there were minor deviations from the objects specified in the offer document, but these have been revised and approved by the shareholders. The company has utilized the proceeds for the purchase of land for a warehouse, which was initially specified for construction, and has also made excess utilization of funds towards issue expenses.